Skip to Main Content

Paper Details

Comparison of HBV-active HAART regimens in an HIV-HBV multinational cohort: outcomes through 144 weeks.
AIDS
17
2015
AIDS, CD4, CD4 T-cell, CONCLUSIONS, HBV, HBV DNA, HIV, HIV-HBV, TDF, aspartate, aspartate aminotransferase, emtricitabine, hepatitis B, hepatitis B e antigen, hepatitis B virus, hepatitis B virus (HBV) DNA, lamivudine, patients, pol, tenofovir disoproxil fumarate
Author NameAffiliation
Chloe L ThioaJohns Hopkins University, Maryland bHarvard School of Public Health, Voluntary Health Services Hospital Campus, Chennai dNational AIDS Research Institute-ICMR, India eUniversity of Zimbabwe Clinical Research Centre, College of Health Sciences, Zimbabwe fCollege of Medicine, Johns Hopkins Research Project, Malawi gNelson R Mandela School of Medicine, University of KwaZulu-Natal, South Africa hUniversity of Colorado School of Medicine, Colorado iBrigham and Women's Hospital, Massachusetts juniversity of california los angeles David Geffen School of Medicine
  • 1 - 1

Datasets